Experiments were performed to determine if L-arginine transport regulates nitric oxide (NO) production and hemodynamics in the renal medulla. The effects of renal medullary interstitial infusion of cationic amino acids, which compete with L-arginine for cellular uptake, on NO levels and blood flow in the medulla were examined in anesthetized rats. NO These results suggest that L-arginine transport by cationic amino acid transport mechanisms is important in the production of NO and maintenance of blood flow in the renal medulla.
Introduction
A number of functional studies provide evidence supporting the concept that endogenous production of nitric oxide (NO) by nitric oxide synthase (NOS) in the kidney may be partially dependent on extracellular L-arginine concentration and cellular L-arginine uptake mechanisms. Both renal perfusion rate and glomerular filtration rate were decreased when Larginine was eliminated from the perfusate of the isolated perfused kidney preparation (32) .
Studies in anesthetized rats have demonstrated that intravenous administration of L-arginine leads to renal vasodilation (8) while cellular L-arginine uptake by the y + transporter appears necessary for the NO-mediated effects on tubuloglomerular feedback (36) . Moreover, the addition of either NO donors or increased extracellular L-arginine concentration inhibited chloride absorption in the isolated perfused thick ascending loop of Henle (31) . Results of these functional studies support the hypothesis that cellular uptake of L-arginine is important in the regulation of NO formation in the kidney.
Supplementation of extracellular L-arginine has also proven beneficial in animal models of hypertension. Chronic oral or intravenous L-arginine administration prevents sodium-dependent hypertension in Dahl salt-sensitive (Dahl S) rats (1, 2, 13, 29, 28) . Consistent with an antihypertensive effect, L-arginine treatment led to a normalization of the pressure natriuresis relationship and increased transmission of pressure into the renal interstitium in anesthetized Dahl S rats (29, 28) . Experiments performed in our laboratory have since demonstrated that sodium-induced hypertension in the Dahl S rats can be prevented by selective infusion of L-arginine into the renal medullary interstitial space (26) , indicating that the antihypertensive effect of L-arginine administration in the Dahl S may be due to alterations in L-arginine availability in the renal medulla. R-00386-2004 4 To further investigate the mechanisms of cellular L-arginine uptake in the renal medulla, we recently reported that L-arginine uptake in the inner medullary collecting duct is mediated by a y + transporter mechanism encoded as cationic amino acid transporter 1 (CAT1).
Experiments with freshly isolated cells from the inner medulla subsequently demonstrated that both L-arginine uptake and NO production could be blocked by the cationic amino acids Lornithine and L-lysine which compete with L-arginine for cationic amino acid transport (38) , and Zou and Cowley demonstrated that intravenous infusion of L-arginine increases NO concentration in both the renal cortex and medulla of anesthetized rats (41) . Moreover, we recently reported that chronic blockade of L-arginine transport in the renal medulla with either an antisense oligonucleotide against CAT1 or the cationic amino acids L-ornithine and Llysine leads to a sustained decrease in NO in the renal medulla and the development of systemic hypertension (14) . These experimental observations indicate that cellular Larginine transport may be a critical factor in NO formation in this portion of the kidney.
Furthermore, the results of these studies raise the possibility that the in vivo ratio of L-arginine to other cationic amino acids may regulate NO production and consequently NO-dependent function in this portion of the kidney. To date, the influence of manipulation of argininetransport mechanisms on the regulation of renal medullary blood flow has not been experimentally investigated.
In the present study we tested the hypotheses that L-arginine transport by a y + mechanism influences NO formation in the renal medulla in vivo, and that an alteration in the balance of L-arginine and other cationic amino acids in the renal medulla affects NO production and NO-dependent function. Initial studies examined the concentration of Larginine and other cationic amino acids in the renal medulla. Studies were then performed to R-00386-2004 5 determine the influence of renal medullary interstitial infusion of the cationic amino acids Lornithine, L-lysine, L-homoarginine, and L-arginine on renal medullary interstitial NO levels and renal medullary blood flow in anesthetized Sprague-Dawley rats. The effects of Larginine and other cationic amino acids on intracellular NO levels in a serum-free, freshlyisolated suspension of renal medullary cells were also studied. Finally, to determine which cationic amino acid transporter is likely affected, quantitative RT-PCR was performed to compare the abundance of CAT1, CAT2, and CAT3 mRNA in the renal cortex and medulla and an immunohistochemistry protocol was performed to examine the distribution of CAT1 in the inner medulla.
Methods

Animals
Male Sprague-Dawley rats weighing between 280 and 350 grams were used in this study. 
Concentration of L-arginine, L-ornithine, and L-lysine in plasma and renal tissue.
Rats were euthanized with an overdose of sodium pentobarbital (100 mg/kg ip). A sample of arterial blood was obtained and spun at 5,000 x g for 15' to separate the plasma. The kidneys were also removed from the rat and grossly divided into renal cortical, outer medullary and inner medullary tissue before snap freezing on dry ice. The samples were kept at -80°C until analysis.
The renal tissue was homogenized using a Potter-Elvehjem tissue grinder at 3,000 rpm in a With 6 repeated injections, the coefficient of variation (CV) for the arginine peak was 0.3% for retention time, 3.3% for peak area and 1.65% for peak height. The calculated concentration of L-arginine in a plasma pool injected 23 times on 6 different days yielded a CV of 5%.
Surgical preparation for microdialysis and laser-Doppler flowmetry
Rats were anesthetized with an injection of Inactin (thiobutabarbital; 100 mg/kg body wt, i.p.) and a tracheotomy was performed. The right jugular vein and the right femoral artery were cannulated with PE-50 to infuse saline (154 mmol/l NaCl) intravenously (5 ml/kg/h) and to measure arterial pressure, respectively. The left kidney was exposed via a flank incision for the R-00386-2004 7 implantation of optical fibers or microdialysis probes. Interstitial infusion catheters were constructed as previously described (18) , inserted into a depth of 5.5 mm, and infused with saline vehicle or saline with amino acids or drugs at a rate of 0.5 ml/hr.
Measurement of NO by oxyhemoglobin-trapping technique
In vivo microdialysis studies in the renal medulla of rats were performed as previously described (15, 14, 41) . Microdialysis probes which permit both infusion and collection of In the experimental protocols saline was infused as a vehicle at a rate of 0.5 ml/hr via the infusion port of the microdialysis probes. After a 120-minute equilibration period, dialysate fluid was collected during a 60-minute control period. Thereafter, L-ornithine (N=8, 1 methyl ester (L-NAME; 100 µg/kg/min) was administered to each group for a final collection period. This large dose of L-NAME was administered to demonstrate the functional effects of a maximum dose of a NOS enzyme inhibitor; L-NAME does not compete with L-arginine for cellular uptake in IMCD (38) or other cell types (34) . To test for the reversibility of the effect of the cationic amino acids, excess L-arginine (N=8, 10 µmol/kg/min) was administered in the final period to a separate group of rats infused in the initial experimental period with L-ornithine (1 µmol/kg/min). As a final set of control experiments, mannitol (N=8, 1 µmol/kg/min) was infused into the interstitial space for both experimental periods to examine the influence of nonspecific osmotic effects of the amino acid solutions on NO in the renal medullary interstitial space.
Laser Doppler Flowmetry
Single mode optical fibers (Edmund Scientific, Barrington, NJ) were inserted into the renal medulla (5.5 mm). The fibers were sheathed with PE-50 and anchored in place on the kidney surface with cyanoacrylate adhesive. Interstitial infusion catheters were constructed as previously described (18) via the optical fiber as previously described (15, 21) .
Laser-Doppler flowmetry experiments were performed on 6 groups of rats. Following a 120-minute equilibration period after surgery, the control level of renal medullary blood flow was obtained during a 30-minute control period in which saline (0.5 ml/hr) was infused into the renal medullary interstitial catheter. The following amino acids in saline were then infused into the renal medulla in separate groups for a 30-minute experimental period: L-ornithine (N=6, 1
µmol/kg/min), and L-NAME (N=7, 1 µmol/kg/min). Mean arterial pressure and medullary blood flow were averaged during the final 5 minutes of each period.
Flow cytometry for DAF-FM-T fluorescence
Isolated renal inner medullary cells were prepared as described (14, 38) , resuspended in 
Quantitative Reverse Transcription-PCR.
Tissue was homogenized in the lysis buffer and RNA was extracted using ABI6700 
Statistics
Data are expressed as mean + SEM. Within-group changes were evaluated with a oneway ANOVA for repeated measurements followed by a Student-Neuman-Keuls post-hoc test.
Between-group changes were evaluated with a two-way ANOVA followed by a StudentNeuman-Keuls post-hoc test. A confidence level of p<0.05 was considered significant.
Results
Concentration of L-arginine, L-ornithine, and L-lysine in plasma and renal tissue.
Initial experiments were performed to determine the concentration of L-arginine and the other cationic amino acids, L-ornithine and L-lysine, in the plasma and renal tissue of SD rats. As illustrated in Figure 1 , the plasma concentration of L-lysine was significantly greater than the concentrations of L-arginine and L-ornithine. In the homogenized kidney tissue, normalized to quantity of tissue protein, the concentration of each amino acid was significantly greater in the renal cortical tissue than in the outer medulla or inner medulla. In the renal cortex the concentration of L-arginine and L-lysine was 6-7 fold greater than the concentration of Lornithine. The L-arginine and L-lysine levels were not significantly different from each other in any of the kidney regions examined; L-ornithine was not detectable in the homogenates of the renal outer and inner medulla.
Effect of infusion of cationic amino acids on NO concentration in the renal medulla
The concentration of NO in situ was evaluated in rat renal medulla by in vivo microdialysis-oxyhemoglobin trapping technique. The summarized data are illustrated in Figure   2 . The baseline NO levels (approximately 120 nmol/l) are in agreement with levels previously reported for the renal medulla (14, 15, 41) . NO concentration in the renal medulla was 
Influence of Cationic Amino Acid Infusion on Renal Medullary Blood Flow
The influence of infusion of the different amino acids and L-NAME on renal medullary blood flow is illustrated in Figure 3 . ranged from 96-126 mmHg during the control period in all groups and was unaltered during interstitial infusion of the cationic amino acids. The MAP significantly increased, however, from 112±4 to 144±2 mmHg during the infusion of this large dose of L-NAME. Nevertheless, medullary interstitial infusion of the NOS inhibitor L-NAME significantly decreased medullary blood flow by 38+4%.
Influence of Cationic Amino Acids on NO in Isolated Renal Inner Medullary Cells
The influence of incubation the cells with the different amino acids, L-NAME, and Dmannitol on the DAF-FM-T fluorescence is illustrated in Figure 4 were partially reversed when L-arginine was added to the cells. In an effect similar to that observed in the microdialysis study, incubation with L-NAME greatly decreased NO production in the cells while mannitol did not alter NO production in the isolated cells. To begin to identify a mechanism for these observed effects, this same experiment was run on two other groups of cells which were incubated with either nonimmune rabbit serum or antisera raised against CAT1.
While the nonimmune serum (1:1000) had no effect on the response to any of the amino acids, addition of a 1:1000 dilution of the anti-CAT1 antisera blunted the increase in NO when additional L-arginine was added to the cells and also attenuated the decrease in NO observed when the cells were incubated with L-ornithine, L-lysine, or L-homoarginine. The addition of the nonimmune sera and the anti-CAT1 sera did not influence DAF-FM fluorescence in the mannitol group or the decrease in NO observed when the NOS inhibitor L-NAME was added to the cells.
Quantification of rat cationic amino acid transporter (CAT) mRNA.
The expression of mRNA for rat CAT1, CAT2, and CAT 3 measured by real-time quantitative reverse transcription-PCR is shown in shown in Figure 5 . The predominant CAT mRNA measured in the brain was CAT1; CAT1 was also the most prevalent mRNA measured in each portion of the kidney. A gradient of CAT1 expression was observed in the kidney; the expression was highest in the inner medulla and least in the renal cortical tissue. In the liver, CAT2 was the most prevalent species measured. Significant levels of CAT3 mRNA were measured only in the brain.
Immunohistochemistry of CAT1 in the renal medulla
An immunohistochemical localization of CAT1 in the renal medulla is shown in Figure 6 .
The immunoreactivity for CAT1 in the renal inner medulla was detected in collecting duct cells (black arrow), the wall of vasa recta (red arrow), and in epithelial cells of the pelvis (green arrow). These observations are consistent with previous studies which have demonstrated that CAT1 is present in IMCD (38) and in endothelial cells (5) .
Discussion
The present experiments demonstrate that the concentration of L-arginine and L-lysine, The present study also addressed the potential mechanism at work in the present study.
In the in vitro studies, the addition of the anti-CAT1 serum decreased the NO response to L to L-citrulline, in freshly isolated IMCD is dependent upon L-arginine transport by a y + -mediated mechanism (38) . The influence of the other cationic amino acids to decrease NO production in freshly isolated cells obtained from the renal medulla was confirmed in the present study by measuring DAF fluorescence. It is therefore possible that renal medullary interstitial infusion of cationic amino acids blocked NO production by the IMCD. Alternatively, other structures in the renal medulla, in particular the vasa recta, also contain relatively large amounts of NOS (20, 39) .
Experiments in the present study indicate that CAT1 mRNA is predominantly expressed in the renal medulla and CAT1 immunoreactive protein is localized in the collecting ducts and vasa recta. The release of NO from any of these structures may therefore have been altered in these experiments
The specific transporter affected by the cationic amino acids was not directly addressed in the in vivo experiments. In previous studies from our laboratory we demonstrated that Larginine uptake in the IMCD was mediated by a y+ transporter encoded as CAT1 (38) . Further studies then demonstrated that chronic infusion of L-ornithine, L-lysine, or an antisense oligonucleotide for CAT1 lead to a sustained decrease in NO in the rat renal medulla which is accompanied by the development of hypertension (14) . Though we did not use agents which specifically targeted individual transporters in the present in vivo experiments, we observed that antisera raised against CAT1 partially blunted the effects of the cationic amino acids on NO in renal medullary cells. This result suggests that CAT1, which has been shown to be the predominant CAT in the rat renal inner medulla (38) , mediates the change in NO caused by cationic amino acids.
The partial dependence of NO production and medullary blood flow on cellular Larginine transport in the renal medulla is surprising since it has been considered that L-arginine is abundantly present in the intracellular space (100-3800 µM) when compared to the K M of 
